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Abstract
Background: Common vaginal infections that manifest in women are usually easily diagnosed.
However, Chlamydia infection is often asymptomatic, leading to infertility before it is detected. If
it occurs in pregnancy, it could lead to significant neonatal morbidity. It may also play a role with
other viral infections for e.g. Human Papilloma Virus in the development of cervical cancer. The
objective of this study was to determine the prevalence of Chlamydia infection in women
undergoing screening for cervical abnormalities as a part of a research project in primary and
secondary care institutions in the United Arab Emirates.
Methods: In this cross sectional study married women attending primary and secondary care
participating in a large nationwide cervical abnormalities screening survey were offered Chlamydia
testing using a commercially available test kit. This kit uses a rapid immunoassay for the direct
detection of Chlamydia trachomatis antigen in endocervical swab specimens. As this study was
performed in a traditional Islamic country, unmarried women were excluded from testing, as the
management of any positive cases would create legal and social problems. All married women
consenting to take part in the study were included irrespective of age.
Results: Of 1039 women approached over a period of eight months 919 (88.5%) agreed to
participate. The number of women in the 16 to 19 years was small (0.01%) and 30% were aged over
40 years. The prevalence of Chlamydia infection in this study was 2.6% (95% confidence interval
1.2–3.3%), which was marginally higher in women screened in secondary care (p = 0.05).
Conclusion: This is one of the few reports on the prevalence of Chlamydia infection in women
from the Middle East. Due to cultural and social constraints this study excluded a large proportion
of women aged less than 19 years of age. Hence no direct comparisons on prevalence could be
made with studies from the West, which all included younger women at high risk of Chlamydia.
However this study emphasizes the importance of cultural factors while interpreting results of
studies from different cultures and communities.
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Background
United Arab Emirates (UAE), situated in the Arabian Gulf
Peninsula, is a young country formed in 1971. Due to the
judicious use of its newfound natural resources, the coun-
try has seen tremendous growth in its infrastructure
including healthcare provision. According to the World
Bank statistics on UAE [1], in the year 2002, the life
expectancy at birth was 75.4 years, infant mortality rate 8
per 1000 and childhood immunisation rates reached
95%. The gross national income per capita in 1998 was
US$ 19,550. Although economic growth has produced a
dramatic improvement in the living conditions of its peo-
ple, it has brought its own problems. There has been an
epidemiological transition in terms of morbidity and
mortality in the Emirates. According to the Ministry of
Health [2], cardiovascular disorders (23.9%), accidents
(16.8%) and cancer (8.3%) accounted for 48.9% of the
total deaths during 1998.
Although UAE is a traditional Islamic society, recent glo-
balisation and rapid economic development have had
their own impact on the health and lifestyle of the popu-
lation. There are anecdotal reports of the practice of pro-
miscuity appearing in certain sections of society. Holiday
travel has also increased over the last decade in the com-
munity. Due to these reasons there is a possibility that sex-
ually transmitted infections (STI) might pose a significant
public health threat in the future. There is no population-
based data on STI in UAE. The first two authors of this
report undertook a population-based study to determine
the prevalence of cervical abnormalities in UAE commu-
nity. As in many previous reports, [3,4] this provided an
ideal opportunity to establish the prevalence of Chlamydia
trachomatis (CT) infection as this information is currently
lacking in UAE.
CT is the most common curable sexually transmitted
infection in the UK [5]. The complications of CT infection
are distressing and expensive, including infertility, ectopic
pregnancy, and chronic pelvic pain [6]. In most countries,
selective screening, in high-risk groups, is recommended
largely because testing for CT is expensive and requires
considerable technical expertise. But it has been argued
[7] that in high prevalence populations, selective screen-
ing should not be used and all women should be
screened.
The prevalence of CT infection varies extensively depend-
ing on the health care setting. It is low in primary care but
very much higher among women attending STI clinics.
Ideally, to establish the prevalence in any community,
screening should be undertaken at a population level.
This may not always be feasible due to logistic difficulties
and the delicate nature of screening for STI in healthy
women. The alternative is to screen women attending pri-
mary and secondary care self-presenting themselves for a
variety of reasons. This study adopted this approach and
attempted to establish the prevalence of Chlamydia tracho-
matis infection in women in Abu Dhabi Emirate, a prov-
ince of UAE to determine the magnitude of this STI in this
community.
Methods
UAE is formed of seven emirates (provinces) and the larg-
est emirate is Abu Dhabi, which covers over 3/4th of the
landmass where nearly 40% of the population live. The
country attracts a large number of expatriates and their
number is equal or in some emirates exceeds the number
of UAE citizens. Due to resource constraints, only women
attending primary and secondary care in Abu Dhabi Emir-
ate were targeted for the Chlamydia prevalence survey.
Both citizens and expatriates were targeted in the survey.
UAE terrain is predominantly desert in nature, hence the
settlements are concentrated in urban areas and a network
of primary health centres serves the population. This sur-
vey was a part of a major study on prevalence of cervical
abnormalities among women in UAE.
Table 1: Chlamydia test refusal by socio demographic variables
Characteristics Chlamydia Swab#
Accepted Refused N (%) Chi2 p value
Age <=Median 487 49 (9.1) 6.5 0.011
>Median 428 71 (14.2)
Education Illiterate 191 14 (6.8) 2.3 0.133
Educated 652 75 (10.3)
Nationality U.A.E. 443 37 (7.7) 13.0 0.000
Non-U.A.E 468 82 (14.9)
Gynecological complaint Yes 714 88 (11.0) 1.1 0.284
No 198 31 (13.5)
# Figures do not always add up to 919 due to missing informationBMC Women's Health 2004, 4 http://www.biomedcentral.com/1472-6874/4/3
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UAE is still largely a traditional Islamic country and pre-
marital sex is apparently very rare due to cultural, legal
and societal taboos. In the only state medical school in the
country there is still gender segregation and men and
women medical students are taught separately. Unmar-
ried women were excluded from testing in this study, as
the management of any positive cases would create legal
and social problems. Premarital sex is illegal in UAE.
"According to the UAE Penal Code, he who indulges in
sexual intercourse with a woman to whom he is not mar-
ried even if it is with her consent, will be sentenced to no
less than a year in jail" [8]. Also women attending the
clinic seeking treatment specifically for vaginal discharge
were excluded from the study as earlier reports show the
prevalence of CT to be higher in these women [9,10].
Twenty-seven out of a total of 42 health centres were
included in the study. These primary health centres were
selected by stratified random sampling, and a ratio of 4:1
was adhered to for urban and rural areas i.e. for every rural
centre four urban centres were selected. The strata were
based on the mean monthly attendance. Chlamydia
swabs were offered opportunistically to women attending
gynaecology clinics during 2000 in five maternity hospi-
tals serving the population of Abu Dhabi Emirate and the
two largest major government hospitals were targeted and
included in the study. An endocervical swab was taken
which was analyzed using one of the commercially avail-
able kits (Clearview) according to standard protocols
described by the manufacturer [11]. This is a rapid
method and provides a simple direct detection assay for
Chlamydia antigen in endocervical swab specimens, for
either single testing or batch use. In this test Chlamydia
antigen is extracted from the specimen by heating the
swabs at 80°C with the Extraction Buffer. This detected all
15 seroversions of Chlamydia.
All positive results were reported back immediately to the
health care providers who took over the responsibility of
prescribing treatment and further management. UAE Uni-
versity medical school's research and ethics committees
approved the study and administrative approval was
obtained from His Excellency the Undersecretary, Minis-
try of Health and from the Director of Primary care, Gov-
ernment of UAE.
Statistical analysis
Data entry and analysis were performed using the statisti-
cal package SPSS version 10 [12]. The quality of the entry
process was checked by re-entering a random sample of
10% of cases and running frequencies to check for
extreme values. In the analysis, appropriate frequencies
were generated. The difference between means of contin-
uous variables was tested by "t" tests and associations
between categorical variables by chi-squared and Fishers's
exact test as appropriate. The prevalence of Chlamydia
infection was analysed by certain sociodemographic and
clinical variables.
Results
Of 1039 women approached, 919 (88.5%) agreed to par-
ticipate and the demographic characteristics of responders
and non-responders are presented in Table 1. One in 4
women reported living in a polygamous marriage.
Women attending primary care contributed to over 63%
of the sample. The overall prevalence of vaginal Chlamy-
dia infection among women was 2.6% and the 95% con-
fidence interval was 1.2 to 3.3%. Prevalence of infection
was lower in women of polygamous marriage (1.9%)
compared to women of monogamous marriage (2.3%)
although this difference was not statistically significant.
Prevalence by source of swabs, participants' age, national-
ity, education and presence of gynaecological complaints
are presented in Table 2.
Discussion
To our knowledge, there have been few studies on the
prevalence of genital Chlamydia infection from the Mid-
dle East [13,14]. A hospital-based study [13] from Jordan
reported a prevalence of 4.6% among symptomatic
patients with urethritis using a cryptic plasmid- based PCR
technique. In our study non-responders differed signifi-
cantly from responders (Table 1). Contrary to a study
from Sweden [15] where younger women refused partici-
pation more often than older women the reverse was true
in our study. This could be due to the different cultural
setting in which these studies were performed. In addi-
tion, non-UAE nationals were more likely to refuse test-
ing. It is possible that non-nationals were concerned
about being labelled as carriers of sexually transmitted
infection; hence there was a higher non-response in this
group. Over 60% of women had attended primary care
and the prevalence of Chlamydia infection was margin-
ally higher in women attending secondary care (Table 2).
As we wanted to study the prevalence of CT in apparently
healthy women, we excluded women who specifically
sought care for vaginal discharge. As these women might
have a higher prevalence of CT infection it is possible that
their exclusion could have led to some underestimation of
prevalence in this population. Although women seeking
treatment for vaginal discharge were excluded, it is possi-
ble that women attending secondary care had pre-existing
genital infections thus the marginally higher prevalence.
The prevalence was highest in the sexually highly active
age group of 16–29 year, i.e. 16–29:2.89% vs 30+: 1.87%.
In comparing prevalence across different studies, one
needs to take in to account the background risk of
included women and the testing technique employed, as
this would influence the prevalence rates. One considera-
tion, which confounds the results of this survey beingBMC Women's Health 2004, 4 http://www.biomedcentral.com/1472-6874/4/3
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compared with studies from other countries, is the age
group of women included in this study. This study only
included married women and excluded unmarried
women aged less than 19 years and over represented
women aged 40 years and over. It is likely that the popu-
lation being studied is at low risk of Chlamydia. However,
in UAE society premarital sex is totally forbidden and any
such activity would lead to punishment by law [8] and
other sanctions by society. Although no figures are availa-
ble on premarital sex from this community anecdotal evi-
dence suggests that even if it exists it is likely to be very
rare. In UAE, clinicians do not often encounter young
unmarried women with STI (Dr. Neriger, Consultant in
Infectious disease, Tawam hospital, Al-Ain, UAE, personal
communication).
The Chlamydia prevalence in this study of 2.6% was sim-
ilar to studies performed in primary care in Sweden
(2.7%) [15] and Greece (3.2%) [16] but was much lower
than studies performed in other populations; Pennsylva-
nia family planning clinics (11.2%) [17], antenatal clinics
in Bangkok (8.6%) [18], pregnant women attending sec-
ondary care in India (17%) [19], and in a US college
gynaecology clinic (8.1%) [20]. As described above the
lower prevalence in our study could be due to the large
number of low risk women included and exclusion of
younger women who could potentially be at a higher risk
of STI.
The prevalence of polygamy was much higher in UAE
(26%) as compared to neighbouring Kuwait [21]
(12.5%). It is possible that the lower prevalence of infec-
tion in women of polygamous marriages could be due to
their husbands having a much lower prevalence of sexu-
ally transmitted infections because they live in a stable
relationship within the marriage setting. Prevalence of
infection did not vary by the presence of any gynaecolog-
ical complaints.
In this survey, Clearview test was employed to determine
the prevalence of infection. This test is easier to perform
with minimum expertise as test kits can be used off the
shelf. The performance of the test varies depending on the
gold standard used to compare the results. The sensitivity
of the test was only 50% when amplification technolo-
gies, the AMP CT (Gen-Probe) and LCx (Abbott) assays
were used as a comparison [22]. However, the sensitivity
rose to 76% when a DAKO IDEIA Chlamydia test was
used as the gold standard [23]. The advantages and disad-
vantages of using Clearview for rapid detection have been
discussed elsewhere [24]. According to this decision anal-
ysis in one off testing situations, rapid tests contribute sig-
nificantly to the detection and treatment of Chlamydia
Table 2: Prevalence of Chlamydia by socio demographic characteristics, source of smear and presence of gynaecological complaints
Characteristic Prevalence of Chlamydia
Positive N (%) Negative N (%)
Source of smear* PHC 9 (1.6) 565 (98.4)
Hospital 12 (3.6)+ 326 (96.4)
Age group (years)& 16–19 1 (8.3) 11 (91.7)
20–29 8 (2.7) 290 (97.3)
30–39 9 (2.8) 315 (97.2)
40–49 1 (0.5) 221 (99.5)
50–59 0 (0) 46 (100)
>=60 1 (16.7) 5 (83.3)
Nationality || UAE 10 (2.3) 433 (97.7)
Gulf countries 2 (2.7) 72 (97.3)
African Arab 3 (3.4) 86 (96.6)
Middle East 2 (1.7) 116 (98.3)
Indian subcontinent 1 (1.0) 96 (99.0)
Others 3 (3.7) 79 (96.3)
Education level** Illiterate 10 (2.3) 433 (97.7)
Primary school 2 (2.7) 72 (97.3)
Secondary school 3 (3.4) 86 (96.6)
College & Higher 2 (1.7) 116 (98.3)
Gynaecological Symptom ++ Positive 16 (2.26) && 691 (97.94)
Negative 4 (2.0) 194 (98.)0
* Source missing in 7 subjects, + Chi2 3.7, p = 0.054, &Age missing in 11 subjects || Nationality missing in 15 subjects, ** Education level missing in 83 
subjects ++ Data on symptoms missing in 14 subjects, &&Symptoms include lower abdominal pain and vaginal dischargeBMC Women's Health 2004, 4 http://www.biomedcentral.com/1472-6874/4/3
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infections among women. As ours was a survey of women
attending health care institutions including primary
health care centres and as the resources, including exper-
tise were limited, we used the Clearview to obtain results
at point of care. In low prevalence situations, tests with
low sensitivity such as Clearview may not be ideal as it has
been reported that even very good tests have low positive
predictive value while testing low prevalence population
[25]. Hence, it is possible that the prevalence in this com-
munity might be higher and this needs further studies
using other tests for Chlamydia, which have a higher
sensitivity.
The US preventive task force [26] has recommended that
all sexually active women aged 25 and younger and other
asymptomatic women at increased risk of infection
should be routinely screened. Due to the selective nature
of women included in our study and the type of test
employed it is hard to arrive at any definite conclusions
on the prevalence of genital Chlamydia based on this
study and hence to put forward any firm recommenda-
tions. However it is worth mentioning here that in our
population, the prevalence of Chlamydia is much lower
than other populations even though 40% were recruited
from secondary care.
Conclusions
In this study performed among a conservative Middle
Eastern society the acceptance of CT testing was high
(89%). The prevalence of CT infection in this population
was 2.6%. The prevalence was marginally higher in
women attending secondary care although it was not dif-
ferent if women had any gynaecological complaints or
not. Due to the exclusion of young women and the type
of test employed no firm conclusions can be drawn on the
prevalence in the population. Further studies are war-
ranted including younger women using more sensitive
tests to screen for Chlamydia. However it remains to be
seen how researchers in future could overcome the legal,
social and logistics constraints we faced while planning to
screen young unmarried women in this traditional Islamic
community. Till such studies become available we pro-
pose selective Chlamydia testing of the population based
on clinical grounds. Our study also emphasises the impor-
tance of cultural factors while interpreting results of stud-
ies from different cultures and communities. Further
epidemiological studies are warranted in this population
to determine the correlates of Chlamydia positivity to
plan preventive activities.
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